O'Brien S, Butticello M, Thompson C, Wilson B, et al. Inhibiting PRMT5 induces DNA damage and increases anti-proliferative activity of Niraparib, a PARP inhibitor, in models of breast and ovarian cancer. BMC Cancer 2023;23:775.
PMID: 37596538